BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ng SC, Tang W, Leong RW, Chen M, Ko Y, Studd C, Niewiadomski O, Bell S, Kamm MA, de Silva HJ, Kasturiratne A, Senanayake YU, Ooi CJ, Ling KL, Ong D, Goh KL, Hilmi I, Ouyang Q, Wang YF, Hu P, Zhu Z, Zeng Z, Wu K, Wang X, Xia B, Li J, Pisespongsa P, Manatsathit S, Aniwan S, Simadibrata M, Abdullah M, Tsang SW, Wong TC, Hui AJ, Chow CM, Yu HH, Li MF, Ng KK, Ching J, Wu JC, Chan FK, Sung JJ; Asia-Pacific Crohn's and Colitis Epidemiology Study ACCESS Group. Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific. Gut 2015;64:1063-71. [PMID: 25217388 DOI: 10.1136/gutjnl-2014-307410] [Cited by in Crossref: 225] [Cited by in F6Publishing: 260] [Article Influence: 28.1] [Reference Citation Analysis]
Number Citing Articles
1 Torres J, Chaparro M, Julsgaard M, Katsanos K, Zelinkova Z, Agrawal M, Ardizzone S, Campmans-Kuijpers M, Dragoni G, Ferrante M, Fiorino G, Flanagan E, Gomes CF, Hart A, Hedin CR, Juillerat P, Mulders A, Myrelid P, O'Toole A, Rivière P, Scharl M, Selinger CP, Sonnenberg E, Toruner M, Wieringa J, Van der Woude CJ. European Crohn's and Colitis Guidelines on Sexuality, Fertility, Pregnancy, and Lactation. J Crohns Colitis 2023;17:1-27. [PMID: 36005814 DOI: 10.1093/ecco-jcc/jjac115] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
2 Li L, Qiu N, Meng Y, Wang C, Mine Y, Keast R, Guyonnet V. Preserved egg white alleviates DSS-induced colitis in mice through the reduction of oxidative stress, modulation of infl ammatory cytokines, NF-κB, MAPK and gut microbiota composition. Food Science and Human Wellness 2023;12:312-323. [DOI: 10.1016/j.fshw.2022.07.021] [Reference Citation Analysis]
3 Tenlik İ, Öztürk Ö, Çoşkun O, Arı D, Bacaksız F, Yüksel M, Yeşil B, Durak MB. EFFECT OF BREASTFEEDING ON RISK OF DEVELOPING INFLAMMATORY BOWEL DISEASE.. [DOI: 10.21203/rs.3.rs-2341901/v1] [Reference Citation Analysis]
4 Yokoyama Y, Ohta Y, Ogasawara S, Kato J, Arai R, Koseki H, Saito M, Kaneko T, Tokunaga M, Oura H, Oike T, Imai Y, Kanayama K, Akizue N, Kumagai J, Taida T, Okimoto K, Saito K, Ooka Y, Matsumura T, Nakagawa T, Arai M, Katsuno T, Fukuda Y, Kitsukawa Y, Kato N. The long-term effect of biologics in patients with ulcerative colitis emerging from a large Japanese cohort. Sci Rep 2022;12:21060. [PMID: 36473879 DOI: 10.1038/s41598-022-25218-x] [Reference Citation Analysis]
5 Wang L, Wang Y, Wang XE, Chen B, Zhang L, Lu X. Causal association between atopic eczema and inflammatory bowel disease: A two‐sample bidirectional Mendelian randomization study of the East Asian population. The Journal of Dermatology 2022. [DOI: 10.1111/1346-8138.16642] [Reference Citation Analysis]
6 Tandon P, Lee E, Jogendran R, Kroeker KI, Dieleman LA, Halloran B, Wong K, Berga KA, Huang V. Breastfeeding Patterns in Mothers with Inflammatory Bowel Disease: A Pilot Prospective Longitudinal Study. Inflamm Bowel Dis 2022;28:1717-24. [PMID: 35099541 DOI: 10.1093/ibd/izab354] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Trakman GL, Lin WYY, Hamilton AL, Wilson-O'Brien AL, Stanley A, Ching JY, Yu J, Mak JWY, Sun Y, Niu J, Miao Y, Lin X, Feng R, Chen M, Shivappa N, Hebert JR, Morrison M, Ng SC, Kamm MA. Processed Food as a Risk Factor for the Development and Perpetuation of Crohn's Disease-The ENIGMA Study. Nutrients 2022;14:3627. [PMID: 36079885 DOI: 10.3390/nu14173627] [Reference Citation Analysis]
8 Preda C, Istrătescu D. Etiology of Ulcerative Colitis. Ulcerative Colitis [Working Title] 2022. [DOI: 10.5772/intechopen.106842] [Reference Citation Analysis]
9 Stavely R, Rahman AA, Sahakian L, Prakash MD, Robinson AM, Hassanzadeganroudsari M, Filippone RT, Fraser S, Eri R, Bornstein JC, Apostolopoulos V, Nurgali K. Divergent Adaptations in Autonomic Nerve Activity and Neuroimmune Signaling Associated With the Severity of Inflammation in Chronic Colitis. Inflamm Bowel Dis 2022;28:1229-43. [PMID: 35380670 DOI: 10.1093/ibd/izac060] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Peng C, Li J, Miao Z, Wang Y, Wu S, Wang Y, Wang S, Cheng R, He F, Shen X. Early life administration of Bifidobacterium bifidum BD-1 alleviates long-term colitis by remodeling the gut microbiota and promoting intestinal barrier development. Front Microbiol 2022;13:916824. [DOI: 10.3389/fmicb.2022.916824] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Nag D, Farr D, Raychaudhuri S, Withey JH. An adult zebrafish model for adherent-invasive Escherichia coli indicates protection from AIEC infection by probiotic E. coli Nissle. iScience 2022;25:104572. [PMID: 35769878 DOI: 10.1016/j.isci.2022.104572] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Bourais I, Elmarrkechy S, Taha D, Mourabit Y, Bouyahya A, El Yadini M, Machich O, El Hajjaji S, El Boury H, Dakka N, Iba N. A Review on Medicinal Uses, Nutritional Value, and Antimicrobial, Antioxidant, Anti-Inflammatory, Antidiabetic, and Anticancer Potential Related to Bioactive Compounds of J. regia. Food Reviews International. [DOI: 10.1080/87559129.2022.2094401] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Attauabi M, Madsen GR, Bendtsen F, Wewer AV, Wilkens R, Ilvemark J, Vladimirova N, Jensen AB, Jensen FK, Hansen SB, Siebner HR, Nielsen YJW, Møller JM, Thomsen HS, Thomsen SF, Ingels HAS, Theede K, Boysen T, Bjerrum JT, Jakobsen C, Dorn-Rasmussen M, Jansson S, Yao Y, Burian EA, Møller FT, Fana V, Wiell C, Terslev L, Østergaard M, Bertl K, Stavropoulos A, Seidelin JB, Burisch J. Influence of Genetics, Immunity and the Microbiome on the Prognosis of Inflammatory Bowel Disease (IBD Prognosis Study): the protocol for a Copenhagen IBD Inception Cohort Study. BMJ Open 2022;12:e055779. [PMID: 35760545 DOI: 10.1136/bmjopen-2021-055779] [Reference Citation Analysis]
14 Moos J, Moos Ł, Brzoza Z. Can smoking have a positive effect on the course of certain diseases? A systematic review. Med Sci Pulse 2022;16:1-16. [DOI: 10.5604/01.3001.0015.8804] [Reference Citation Analysis]
15 Goh XT, Fong SK, Chai HC, Kee BP, Chua KH. The first association study of Protein Tyrosine Phosphatase, Non-Receptor Type 2 (PTPN2) gene polymorphisms in Malaysian patients with Crohn's disease. Gene 2022;836:146661. [PMID: 35680018 DOI: 10.1016/j.gene.2022.146661] [Reference Citation Analysis]
16 Mak JWY, Yang S, Stanley A, Lin X, Morrison M, Ching JYL, Niu J, Wilson‐o'brien AL, Feng R, Tang W, Hamilton AL, Or L, Trakman GL, Lin WYY, Sung JJY, Chen MH, Mao Y, Kamm MA, Ng SC. Childhood antibiotics as a risk factor for Crohn's disease: The ENIGMA International Cohort Study. JGH Open. [DOI: 10.1002/jgh3.12755] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Banerjee R, Pal P, Hilmi I, Ghoshal UC, Desai DC, Rahman MM, Dutta U, Mohiuddin SA, Al Mohannadi M, Philip M, Ramesh GN, Niriella MA, De Silva AP, de Silva HJ, Pisespongsa P, Limsrivilai J, Aniwan S, Nawarathne M, Fernandopulle N, Aye TT, Ni N, Al Awadhi S, Joshi N, Ngoc PTV, Kieu TV, Nguyen AD, Abdullah M, Ali E, Zeid A, Sollano JD, Saberi B, Omar M, Mohsin MN, Aftab H, Wai TM, Shastri YM, Chaudhuri S, Ahmed F, Bhatia SJ, Travis SPL; Inflammatory Bowel Disease-Emerging Nations' Consortium (IBD-ENC) study group. Emerging inflammatory bowel disease demographics, phenotype, and treatment in South Asia, South-East Asia, and Middle East: Preliminary findings from the Inflammatory Bowel Disease-Emerging Nations' Consortium. J Gastroenterol Hepatol 2022;37:1004-15. [PMID: 35178742 DOI: 10.1111/jgh.15801] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 Kedia S, Ahuja V. Does the road to primary prevention of inflammatory bowel disease start from childhood? JGH Open 2022;6:365-368. [DOI: 10.1002/jgh3.12782] [Reference Citation Analysis]
19 Gordon H, Blad W, Trier Møller F, Orchard T, Steel A, Trevelyan G, Ng S, Harbord M. UK IBD Twin Registry: Concordance and Environmental Risk Factors of Twins with IBD. Dig Dis Sci 2022;67:2444-50. [PMID: 34097167 DOI: 10.1007/s10620-021-07080-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
20 Nishikawa A, Tanaka K, Miyake Y, Nagata C, Furukawa S, Andoh A, Yokoyama T, Yoshimura N, Mori K, Ninomiya T, Yamamoto Y, Takeshita E, Ikeda Y, Saito M, Ohashi K, Imaeda H, Kakimoto K, Higuchi K, Nunoi H, Mizukami Y, Suzuki S, Hiraoka S, Okada H, Kawasaki K, Higashiyama M, Hokari R, Miura H, Miyake T, Kumagi T, Kato H, Hato N, Sayama K, Hiasa Y; Japan Ulcerative Colitis Study Group. Active and passive smoking and risk of ulcerative colitis: A case-control study in Japan. J Gastroenterol Hepatol 2022;37:653-9. [PMID: 34845747 DOI: 10.1111/jgh.15745] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Santana PT, Rosas SLB, Ribeiro BE, Marinho Y, de Souza HSP. Dysbiosis in Inflammatory Bowel Disease: Pathogenic Role and Potential Therapeutic Targets. Int J Mol Sci 2022;23:3464. [PMID: 35408838 DOI: 10.3390/ijms23073464] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
22 Kakiuchi T, Yoshiura M. Japanese pediatric patient with moderately active ulcerative colitis successfully treated with ustekinumab: A case report. Medicine (Baltimore) 2022;101:e28873. [PMID: 35363198 DOI: 10.1097/MD.0000000000028873] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Almofarreh A, Sheerah HA, Arafa A, Ahamed SS, Alzeer O, Al-hunaishi W, Mhimed MM, Al-hazmi A, Lim SH. Beverage Consumption and Ulcerative Colitis: A Case-Control Study from Saudi Arabia. IJERPH 2022;19:2287. [DOI: 10.3390/ijerph19042287] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Zhao M, Feng R, Ben-Horin S, Zhuang X, Tian Z, Li X, Ma R, Mao R, Qiu Y, Chen M. Systematic review with meta-analysis: environmental and dietary differences of inflammatory bowel disease in Eastern and Western populations. Aliment Pharmacol Ther 2022;55:266-76. [PMID: 34820868 DOI: 10.1111/apt.16703] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
25 Furuya Y, Fukai K, Nakazawa S, Kojimahara N, Hoshi K, Toyota A, Tatemichi M. Occupational physical activity differentially affects the risk for developing later-onset Crohn's disease and ulcerative colitis among middle-aged and older populations. Scand J Gastroenterol 2022;57:206-13. [PMID: 34762552 DOI: 10.1080/00365521.2021.1999495] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
26 Nehlig A. Effects of Coffee on the Gastro-Intestinal Tract: A Narrative Review and Literature Update. Nutrients 2022;14:399. [PMID: 35057580 DOI: 10.3390/nu14020399] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
27 Schineis C. Colitis ulcerosa. Springer Reference Medizin 2022. [DOI: 10.1007/978-3-662-61724-3_72-1] [Reference Citation Analysis]
28 Peters V, Bolte L, Schuttert EM, Andreu-Sánchez S, Dijkstra G, Weersma RK, Campmans-Kuijpers MJE. Western and Carnivorous Dietary Patterns are Associated with Greater Likelihood of IBD Development in a Large Prospective Population-based Cohort. J Crohns Colitis 2022;16:931-9. [PMID: 34864946 DOI: 10.1093/ecco-jcc/jjab219] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
29 Watanabe J, Furukawa S, Yagi S, Shiraishi K, Hanayama M, Tange K, Hashimoto Y, Kitahata S, Mori K, Ninomiya T, Suzuki S, Shibata N, Murakami H, Ohashi K, Hasebe A, Tomida H, Yamamoto Y, Takeshita E, Ikeda Y, Hiasa Y. Time spent per day in strenuous activity and total physical activity are inversely associated with mucosal healing but not with clinical remission in patients with ulcerative colitis. Ann Gastroenterol 2021;34:796-801. [PMID: 34815645 DOI: 10.20524/aog.2021.0663] [Reference Citation Analysis]
30 Du Y, Ding L, Na L, Sun T, Sun X, Wang L, He S, Wang Z, Lu Z, Li F, Guo X, Zhang Y, Tian J, Wang B, Zhai S, Yang C, Liu X. Prevalence of Chronic Diseases and Alterations of Gut Microbiome in People of Ningxia China During Urbanization: An Epidemiological Survey. Front Cell Infect Microbiol 2021;11:707402. [PMID: 34804988 DOI: 10.3389/fcimb.2021.707402] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
31 Cui G, Liu H, Xu G, Laugsand JB, Pang Z. Exploring Links Between Industrialization, Urbanization, and Chinese Inflammatory Bowel Disease. Front Med (Lausanne) 2021;8:757025. [PMID: 34778319 DOI: 10.3389/fmed.2021.757025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
32 Lee WS, Song ZL, Wong SY, Gan CW, Koay ZL, Em JM, Chong SY, Lim CB, Wong SY, Chew KS, Kam CC. Environmental risk factors for inflammatory bowel disease: A case control study in Southeast Asian children. J Paediatr Child Health 2021. [PMID: 34761458 DOI: 10.1111/jpc.15830] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Tavakoli P, Vollmer-Conna U, Hadzi-Pavlovic D, Grimm MC. A Review of Inflammatory Bowel Disease: A Model of Microbial, Immune and Neuropsychological Integration. Public Health Rev 2021;42:1603990. [PMID: 34692176 DOI: 10.3389/phrs.2021.1603990] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
34 Khademi Z, Milajerdi A, Larijani B, Esmaillzadeh A. Dietary Intake of Total Carbohydrates, Sugar and Sugar-Sweetened Beverages, and Risk of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Prospective Cohort Studies. Front Nutr 2021;8:707795. [PMID: 34660658 DOI: 10.3389/fnut.2021.707795] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
35 Chiba M, Morita N, Nakamura A, Tsuji K, Harashima E. Increased Incidence of Inflammatory Bowel Disease in Association with Dietary Transition (Westernization) in Japan. JMA J 2021;4:347-57. [PMID: 34796289 DOI: 10.31662/jmaj.2021-0038] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Piovani D, Pansieri C, Kotha SRR, Piazza AC, Comberg CL, Peyrin-Biroulet L, Danese S, Bonovas S. Ethnic Differences in the Smoking-related Risk of Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. J Crohns Colitis 2021;15:1658-78. [PMID: 33721889 DOI: 10.1093/ecco-jcc/jjab047] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
37 Kim HJ, Shah SC, Hann HJ, Kazmi SZ, Kang T, Lee JH, Kim KB, Kang MJ, Ahn HS. Familial Risk of Inflammatory Bowel Disease: A Population-Based Cohort Study in South Korea. Clin Gastroenterol Hepatol 2021;19:2128-2137.e15. [PMID: 33010407 DOI: 10.1016/j.cgh.2020.09.054] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
38 Yang S. Current status of inflammatory bowel diseases in Korea. J Korean Med Assoc 2021;64:572-7. [DOI: 10.5124/jkma.2021.64.9.572] [Reference Citation Analysis]
39 Wu Z, Huang S, Li T, Li N, Han D, Zhang B, Xu ZZ, Zhang S, Pang J, Wang S, Zhang G, Zhao J, Wang J. Gut microbiota from green tea polyphenol-dosed mice improves intestinal epithelial homeostasis and ameliorates experimental colitis. Microbiome 2021;9:184. [PMID: 34493333 DOI: 10.1186/s40168-021-01115-9] [Cited by in Crossref: 60] [Cited by in F6Publishing: 63] [Article Influence: 30.0] [Reference Citation Analysis]
40 Jain M, Venkataraman J. Inflammatory bowel disease: An Indian perspective. Indian J Med Res 2021;153:421-30. [PMID: 34380788 DOI: 10.4103/ijmr.IJMR_936_18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
41 Chapkin RS, Davidson LA, Park H, Jin UH, Fan YY, Cheng Y, Hensel ME, Landrock KK, Allred C, Menon R, Klemashevich C, Jayaraman A, Safe S. Role of the Aryl Hydrocarbon Receptor (AhR) in Mediating the Effects of Coffee in the Colon. Mol Nutr Food Res 2021;65:e2100539. [PMID: 34406707 DOI: 10.1002/mnfr.202100539] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
42 Zou J, Liu C, Jiang S, Qian D, Duan J. Cross Talk between Gut Microbiota and Intestinal Mucosal Immunity in the Development of Ulcerative Colitis. Infect Immun 2021;89:e0001421. [PMID: 33526559 DOI: 10.1128/IAI.00014-21] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
43 Milajerdi A, Ebrahimi-Daryani N, Dieleman LA, Larijani B, Esmaillzadeh A. Association of Dietary Fiber, Fruit, and Vegetable Consumption with Risk of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Adv Nutr 2021;12:735-43. [PMID: 33186988 DOI: 10.1093/advances/nmaa145] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
44 Agrawal M, Corn G, Shrestha S, Nielsen NM, Frisch M, Colombel JF, Jess T. Inflammatory bowel diseases among first-generation and second-generation immigrants in Denmark: a population-based cohort study. Gut 2021;70:1037-43. [PMID: 32895335 DOI: 10.1136/gutjnl-2020-321798] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
45 Liu TC, Kern JT, Jain U, Sonnek NM, Xiong S, Simpson KF, VanDussen KL, Winkler ES, Haritunians T, Malique A, Lu Q, Sasaki Y, Storer C, Diamond MS, Head RD, McGovern DPB, Stappenbeck TS. Western diet induces Paneth cell defects through microbiome alterations and farnesoid X receptor and type I interferon activation. Cell Host Microbe 2021;29:988-1001.e6. [PMID: 34010595 DOI: 10.1016/j.chom.2021.04.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 11.5] [Reference Citation Analysis]
46 Agrawal M, Sabino J, Frias-Gomes C, Hillenbrand CM, Soudant C, Axelrad JE, Shah SC, Ribeiro-Mourão F, Lambin T, Peter I, Colombel JF, Narula N, Torres J. Early life exposures and the risk of inflammatory bowel disease: Systematic review and meta-analyses. EClinicalMedicine 2021;36:100884. [PMID: 34308303 DOI: 10.1016/j.eclinm.2021.100884] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
47 Rana MN, Lu J, Xue E, Ruan J, Liu Y, Zhang L, Dhar R, Li Y, Hu Z, Zhou J, Ma W, Tang H. PDE9 Inhibitor PF-04447943 Attenuates DSS-Induced Colitis by Suppressing Oxidative Stress, Inflammation, and Regulating T-Cell Polarization. Front Pharmacol 2021;12:643215. [PMID: 33967779 DOI: 10.3389/fphar.2021.643215] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
48 Hagan M, Hayee BH, Rodriguez-Mateos A. (Poly)phenols in Inflammatory Bowel Disease and Irritable Bowel Syndrome: A Review. Molecules 2021;26:1843. [PMID: 33805938 DOI: 10.3390/molecules26071843] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
49 Liang Y, Liu M, Pu J, Zhu Z, Gao Z, Zhou Q, Gu Q, Li P. Probiotics and Their Metabolites Ameliorate Inflammatory Bowel Disease: A Critical Review. Infectious Microbes and Diseases 2021;3:4-13. [DOI: 10.1097/im9.0000000000000046] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
50 Piovani D, Pansieri C, Peyrin-Biroulet L, Danese S, Bonovas S. Confounding and bias in observational studies in inflammatory bowel disease: a meta-epidemiological study. Aliment Pharmacol Ther 2021;53:712-21. [PMID: 33296517 DOI: 10.1111/apt.16222] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
51 Zhou Y, He Y, Liu L, Zhou W, Wang P, Hu H, Nie Y, Chen Y. Alterations in Gut Microbial Communities Across Anatomical Locations in Inflammatory Bowel Diseases. Front Nutr 2021;8:615064. [PMID: 33718417 DOI: 10.3389/fnut.2021.615064] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
52 Zielińska D, Zieliński H, Laparra-Llopis JM, Szawara-Nowak D, Honke J, Giménez-Bastida JA. Caffeic Acid Modulates Processes Associated with Intestinal Inflammation. Nutrients 2021;13:554. [PMID: 33567596 DOI: 10.3390/nu13020554] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 10.5] [Reference Citation Analysis]
53 Zhuang X, Liu C, Zhan S, Tian Z, Li N, Mao R, Zeng Z, Chen M. Gut Microbiota Profile in Pediatric Patients With Inflammatory Bowel Disease: A Systematic Review. Front Pediatr 2021;9:626232. [PMID: 33604319 DOI: 10.3389/fped.2021.626232] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
54 Georgiou AN, Ntritsos G, Papadimitriou N, Dimou N, Evangelou E. Cigarette Smoking, Coffee Consumption, Alcohol Intake, and Risk of Crohn's Disease and Ulcerative Colitis: A Mendelian Randomization Study. Inflamm Bowel Dis 2021;27:162-8. [PMID: 32628751 DOI: 10.1093/ibd/izaa152] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
55 Ratajczak AE, Szymczak-Tomczak A, Zawada A, Rychter AM, Dobrowolska A, Krela-Kaźmierczak I. Does Drinking Coffee and Tea Affect Bone Metabolism in Patients with Inflammatory Bowel Diseases? Nutrients 2021;13:216. [PMID: 33451170 DOI: 10.3390/nu13010216] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
56 Yaser M. Rayyan, Tamara R. Qalqili, Awni T. Abu-sneineh, Reema F. Tayyem. Nutrients Consumed by the Inflammatory Bowel Disease Jordanian Patients. Ann Cancer Res Therap 2021;29:22-9. [DOI: 10.4993/acrt.29.22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
57 Zhao M, Feng R, Ben-horin S, Zhuang X, Tian Z, Zhu Y, Tang C, Li X, Ma R, Mao R, Zhang S, Lin X, Chen B, He Y, Zeng Z, Qiu Y, Chen M. A Meta-Analysis of Environmental and Dietary Risk Factors for Inflammatory Bowel Disease: A Comparison Between Eastern and Western Populations. SSRN Journal. [DOI: 10.2139/ssrn.3796865] [Reference Citation Analysis]
58 Arora N, Prasad A. The Good Side of Evil: Harnessing the Power of Helminths as Therapeutics. Microorganisms for Sustainability 2021. [DOI: 10.1007/978-981-16-1947-2_1] [Reference Citation Analysis]
59 Kaplan GG, Windsor JW. The four epidemiological stages in the global evolution of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 2021;18:56-66. [PMID: 33033392 DOI: 10.1038/s41575-020-00360-x] [Cited by in Crossref: 187] [Cited by in F6Publishing: 168] [Article Influence: 93.5] [Reference Citation Analysis]
60 Katsidzira L, Mudombi WF, Makunike-Mutasa R, Yilmaz B, Blank A, Rogler G, Macpherson A, Vavricka S, Gangaidzo I, Misselwitz B. Inflammatory bowel disease in sub-Saharan Africa: a protocol of a prospective registry with a nested case-control study. BMJ Open 2020;10:e039456. [PMID: 33371021 DOI: 10.1136/bmjopen-2020-039456] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
61 van der Sloot KWJ, Weersma RK, Alizadeh BZ, Dijkstra G. Identification of Environmental Risk Factors Associated With the Development of Inflammatory Bowel Disease. J Crohns Colitis 2020;14:1662-71. [PMID: 32572465 DOI: 10.1093/ecco-jcc/jjaa114] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
62 Jain M, Venkataraman J. Identification of demographic and environmental factors predisposing to ulcerative colitis in southern India. Indian J Gastroenterol 2020;39:619-20. [PMID: 33058002 DOI: 10.1007/s12664-020-01036-9] [Reference Citation Analysis]
63 Kamalova AA, Safina ER, Nizamova RA, Zaynetdinova MS, Kvitko EM. Nutrition of children with inflammatory bowel disease. Ross vestn perinatol pediatr 2020;65:145-51. [DOI: 10.21508/1027-4065-2020-65-5-145-151] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
64 Karmiris K. Racial Differences in Inflammatory Bowel Disease: A Race With Alternating Winners? Inflamm Bowel Dis 2020;26:1878-9. [PMID: 32144931 DOI: 10.1093/ibd/izaa022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
65 Carreras-Torres R, Ibáñez-Sanz G, Obón-Santacana M, Duell EJ, Moreno V. Identifying environmental risk factors for inflammatory bowel diseases: a Mendelian randomization study. Sci Rep 2020;10:19273. [PMID: 33159156 DOI: 10.1038/s41598-020-76361-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
66 Kalra P, John A, Jaleel R, Simon EG, Babji S, Joseph AJ. Prevalence of past hepatitis A infection among Crohn's patients and controls - An examination of the 'hygiene hypothesis', and the need for hepatitis A vaccination. Trop Doct 2021;51:193-7. [PMID: 33050841 DOI: 10.1177/0049475520961949] [Reference Citation Analysis]
67 Rezayat F, Hashempur MH, Tavahen H, Salmanroghani H, Emtiazy M. The efficacy of Ramak (a traditional herbal medicine preparation) for patients with ulcerative colitis: A pilot, randomized, triple-blinded, placebo-controlled clinical trial. European Journal of Integrative Medicine 2020;39:101209. [DOI: 10.1016/j.eujim.2020.101209] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
68 Wang L, An J, Song S, Mei M, Li W, Ding F, Liu S. Electroacupuncture preserves intestinal barrier integrity through modulating the gut microbiota in DSS-induced chronic colitis. Life Sci 2020;261:118473. [PMID: 32971101 DOI: 10.1016/j.lfs.2020.118473] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
69 Qiu Y, Ren W, Liu Y, Chen WE, Pan XH, Ren JJ. Disease burden of inflammatory bowel disease in China from 1990 to 2017: Findings from the global burden of diseases 2017. EClinicalMedicine 2020;27:100544. [PMID: 33150321 DOI: 10.1016/j.eclinm.2020.100544] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
70 Zareef R, Younis N, Mahfouz R. Inflammatory bowel disease: A key role for microbiota? Meta Gene 2020;25:100713. [DOI: 10.1016/j.mgene.2020.100713] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
71 Lo CH, Lochhead P, Khalili H, Song M, Tabung FK, Burke KE, Richter JM, Giovannucci EL, Chan AT, Ananthakrishnan AN. Dietary Inflammatory Potential and Risk of Crohn's Disease and Ulcerative Colitis. Gastroenterology 2020;159:873-883.e1. [PMID: 32389666 DOI: 10.1053/j.gastro.2020.05.011] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 18.3] [Reference Citation Analysis]
72 Banerjee R, Pal P, Nugent Z, Ganesh G, Adigopula B, Pendyala S, Bernstein CN. IBD in India: Similar Phenotype but Different Demographics Than the West. J Clin Gastroenterol 2020;54:725-32. [PMID: 31770158 DOI: 10.1097/MCG.0000000000001282] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
73 Malesza IJ, Malesza M, Krela-Kaźmierczak I, Zielińska A, Souto EB, Dobrowolska A, Eder P. Primary Humoral Immune Deficiencies: Overlooked Mimickers of Chronic Immune-Mediated Gastrointestinal Diseases in Adults. Int J Mol Sci 2020;21:E5223. [PMID: 32718006 DOI: 10.3390/ijms21155223] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
74 Castellano F, Alessio G, Palmisano C. Ocular manifestations of inflammatory bowel diseases: an update for gastroenterologists. Minerva Gastroenterol (Torino) 2021;67:91-100. [PMID: 32677418 DOI: 10.23736/S2724-5985.20.02727-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
75 Chen B, Gao X, Zhong J, Ren J, Zhu X, Liu Z, Wu K, Kalabic J, Yu Z, Huang B, Kwatra N, Doan T, Robinson AM, Chen MH. Efficacy and safety of adalimumab in Chinese patients with moderately to severely active Crohn's disease: results from a randomized trial. Therap Adv Gastroenterol 2020;13:1756284820938960. [PMID: 32733600 DOI: 10.1177/1756284820938960] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
76 Snell A, Segal J, Limdi J, Banerjee R. Inflammatory bowel disease in India: challenges and opportunities. Frontline Gastroenterol 2021;12:390-6. [PMID: 35401961 DOI: 10.1136/flgastro-2020-101500] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
77 Feakins RM. Complications of Inflammatory Bowel Disease. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.024] [Reference Citation Analysis]
78 Andrews T, Campbell F. Assessment of Gastric Biopsies. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.013] [Reference Citation Analysis]
79 Feakins RM. Inflammatory Bowel Disease and the Upper Gastrointestinal Tract. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.017] [Reference Citation Analysis]
80 Feakins RM. Normal Lower Gastrointestinal Mucosa. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.018] [Reference Citation Analysis]
81 Preface. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.001] [Reference Citation Analysis]
82 Non-Neoplastic Pathology of the Gastrointestinal Tract. 2020. [DOI: 10.1017/9781316823026] [Reference Citation Analysis]
83 M. Ho-yen C, Chang F. Coeliac Disease. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.016] [Reference Citation Analysis]
84 Borralho-nunes P. Paediatric Conditions. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.008] [Reference Citation Analysis]
85 Adamczyk LA, Shepherd NA. Diverticular Disease, Mucosal Prolapse, and Related Conditions. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.027] [Reference Citation Analysis]
86 Geboes K, Jouret-mourin A. Jejunitis and Ileitis. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.020] [Reference Citation Analysis]
87 M. Feakins R. Radiation and the Gastrointestinal Tract. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.004] [Reference Citation Analysis]
88 Panarelli NC. Infectious Disorders of the Lower Gastrointestinal Tract. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.019] [Reference Citation Analysis]
89 Parisinos C, Sehgal V, Parkes G. The Value of Gastrointestinal Biopsy. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.002] [Reference Citation Analysis]
90 Celli R, Zhang X. Gastrointestinal Ischemia and Vascular Disorders. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.007] [Reference Citation Analysis]
91 Moorghen M. Non-Neoplastic Diseases of the Anal Canal. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.028] [Reference Citation Analysis]
92 Svrcek M, Feakins RM. Gastrointestinal Dysplasia. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.009] [Reference Citation Analysis]
93 Wong N. Transplantation, Immunodeficiency, and Immunosuppression. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.005] [Reference Citation Analysis]
94 Loughrey MB. Microscopic Colitis. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
95 Walsh SV. Infections of the Oesophagus and Rare Forms of Oesophagitis. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.012] [Reference Citation Analysis]
96 Walsh SV, Feakins RM. Ileal Pouch Anal Anastomosis. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.026] [Reference Citation Analysis]
97 Mccarthy A, Sheahan K. Drug-Induced Gastrointestinal Disease. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.006] [Reference Citation Analysis]
98 Bateman AC. Gastrointestinal Involvement by Systemic Disease. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.003] [Reference Citation Analysis]
99 Index. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.029] [Reference Citation Analysis]
100 Feakins RM. Normal Oesophageal, Gastric and Duodenal Mucosa. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.010] [Reference Citation Analysis]
101 Assarzadegan N, Pezhouh MK. Histology of Gastroesophageal Reflux Disease and Barrett’s Oesophagus. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.011] [Reference Citation Analysis]
102 Andrews T, Campbell F. Types of Gastritis. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.014] [Reference Citation Analysis]
103 Feakins RM. Approach to Reporting Inflammatory Bowel Disease Biopsies. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
104 Feakins RM. Mimics of Inflammatory Bowel Disease. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
105 Feakins RM. Inflammatory Bowel Disease Diagnosis. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
106 Clarke L, Feakins RM. Duodenitis. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.015] [Reference Citation Analysis]
107 Salgado VCL, Luiz RR, Boéchat NLF, Leão IS, Schorr BDC, Parente JML, Lima DC, Silveira Júnior ES, Silva GOS, Almeida NP, Vieira A, de Bueno MLQ, Chebli JM, Bertges ÉR, Brugnara LMDC, Junqueira Neto C, Campbell SBG, Discacciati LL, Cézar JPS, Nunes T, Kaplan GG, Zaltman C. Risk factors associated with inflammatory bowel disease: A multicenter case-control study in Brazil. World J Gastroenterol 2020; 26(25): 3611-3624 [PMID: 32742130 DOI: 10.3748/wjg.v26.i25.3611] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
108 Xie Y, Zhou L, Yao X, Li Y. Protective Effects of Clostridium Butyricum in a Murine Model of Dextran Sodium Sulfate-Induced Colitis That Involve Inhibition of the TLR2 Signaling Pathway and T Helper 17 Cells. Am J Med Sci 2020;360:176-91. [PMID: 32553747 DOI: 10.1016/j.amjms.2020.05.021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
109 Wei M, Gao X, Liu L, Li Z, Wan Z, Dong Y, Chen X, Niu Y, Zhang J, Yang G. Visceral Adipose Tissue Derived Exosomes Exacerbate Colitis Severity via Pro-inflammatory MiRNAs in High Fat Diet Fed Mice. ACS Nano 2020;14:5099-110. [PMID: 32275391 DOI: 10.1021/acsnano.0c01860] [Cited by in Crossref: 45] [Cited by in F6Publishing: 51] [Article Influence: 15.0] [Reference Citation Analysis]
110 Yeshi K, Ruscher R, Hunter L, Daly NL, Loukas A, Wangchuk P. Revisiting Inflammatory Bowel Disease: Pathology, Treatments, Challenges and Emerging Therapeutics Including Drug Leads from Natural Products. J Clin Med 2020;9:E1273. [PMID: 32354192 DOI: 10.3390/jcm9051273] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 15.3] [Reference Citation Analysis]
111 Roda G, Chien Ng S, Kotze PG, Argollo M, Panaccione R, Spinelli A, Kaser A, Peyrin-Biroulet L, Danese S. Crohn's disease.Nat Rev Dis Primers. 2020;6:22. [PMID: 32242028 DOI: 10.1038/s41572-020-0156-2] [Cited by in Crossref: 162] [Cited by in F6Publishing: 172] [Article Influence: 54.0] [Reference Citation Analysis]
112 Hu B, Yu S, Shi C, Gu J, Shao Y, Chen Q, Li Y, Mezzenga R. Amyloid-Polyphenol Hybrid Nanofilaments Mitigate Colitis and Regulate Gut Microbial Dysbiosis. ACS Nano 2020;14:2760-76. [PMID: 31961657 DOI: 10.1021/acsnano.9b09125] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 17.0] [Reference Citation Analysis]
113 Zou Y, Wu L, Xu W, Zhou X, Ye K, Xiong H, Song C, Xie Y. Correlation between antibiotic use in childhood and subsequent inflammatory bowel disease: a systematic review and meta-analysis. Scand J Gastroenterol 2020;55:301-11. [PMID: 32180472 DOI: 10.1080/00365521.2020.1737882] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
114 Algethmi W, Baumann C, Alnajjar W, Sroji A, Alsahafi M, Jawa H, Qari Y, Peyrin-Biroulet L, Saadah OI, Mosli M. Environmental exposures and the risk of inflammatory bowel disease: a case-control study from Saudi Arabia. Eur J Gastroenterol Hepatol 2020;32:358-64. [PMID: 31851095 DOI: 10.1097/MEG.0000000000001619] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
115 Mak WY, Zhao M, Ng SC, Burisch J. The epidemiology of inflammatory bowel disease: East meets west. J Gastroenterol Hepatol 2020;35:380-9. [PMID: 31596960 DOI: 10.1111/jgh.14872] [Cited by in Crossref: 158] [Cited by in F6Publishing: 148] [Article Influence: 52.7] [Reference Citation Analysis]
116 Wu ZC, Zhao ZL, Deng JP, Huang JT, Wang YF, Wang ZP. Sanhuang Shu'ai decoction alleviates DSS-induced ulcerative colitis via regulation of gut microbiota, inflammatory mediators and cytokines. Biomed Pharmacother 2020;125:109934. [PMID: 32058214 DOI: 10.1016/j.biopha.2020.109934] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
117 Troelsen FS, Jick S. Antibiotic Use in Childhood and Adolescence and Risk of Inflammatory Bowel Disease: A Case-Control Study in the UK Clinical Practice Research Datalink. Inflamm Bowel Dis 2020;26:440-7. [PMID: 31265060 DOI: 10.1093/ibd/izz137] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
118 Ali F, Lui K, Wang A, Day AS, Leach ST. The perinatal period, the developing intestinal microbiome and inflammatory bowel diseases: What links early life events with later life disease? Journal of the Royal Society of New Zealand 2020;50:371-83. [DOI: 10.1080/03036758.2019.1706586] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
119 Bischoff SC, Escher J, Hébuterne X, Kłęk S, Krznaric Z, Schneider S, Shamir R, Stardelova K, Wierdsma N, Wiskin AE, Forbes A. ESPEN practical guideline: Clinical Nutrition in inflammatory bowel disease. Clin Nutr 2020;39:632-53. [PMID: 32029281 DOI: 10.1016/j.clnu.2019.11.002] [Cited by in Crossref: 113] [Cited by in F6Publishing: 121] [Article Influence: 37.7] [Reference Citation Analysis]
120 Knyazev O, Shkurko T, Kagramanova A, Veselov A, Nikonov E. Epidemiology of inflammatory bowel disease. State of the problem (review). Dok gastroenterol 2020;9:66. [DOI: 10.17116/dokgastro2020902166] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
121 Digby-Bell JL, Atreya R, Monteleone G, Powell N. Interrogating host immunity to predict treatment response in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 2020;17:9-20. [PMID: 31767987 DOI: 10.1038/s41575-019-0228-5] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 18.0] [Reference Citation Analysis]
122 Gheibipour H, Rahimian G, Ahmadi A. Risk Factors for Ulcerative Colitis in Shahrekord, Iran: A Case-Control Study. Int J Epidemiol Res 2019;6:144-148. [DOI: 10.15171/ijer.2019.25] [Reference Citation Analysis]
123 Zhang Y, Yan T, Sun D, Xie C, Wang T, Liu X, Wang J, Wang Q, Luo Y, Wang P, Yagai T, Krausz KW, Yang X, Gonzalez FJ. Rutaecarpine inhibits KEAP1-NRF2 interaction to activate NRF2 and ameliorate dextran sulfate sodium-induced colitis. Free Radic Biol Med 2020;148:33-41. [PMID: 31874248 DOI: 10.1016/j.freeradbiomed.2019.12.012] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 8.0] [Reference Citation Analysis]
124 He Y, Li X, Yu H, Ge Y, Liu Y, Qin X, Jiang M, Wang X. The Functional Role of Fecal Microbiota Transplantation on Dextran Sulfate Sodium-Induced Colitis in Mice. Front Cell Infect Microbiol 2019;9:393. [PMID: 31803633 DOI: 10.3389/fcimb.2019.00393] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
125 Bigeh A, Sanchez A, Maestas C, Gulati M. Inflammatory bowel disease and the risk for cardiovascular disease: Does all inflammation lead to heart disease?Trends Cardiovasc Med. 2020;30:463-469. [PMID: 31653485 DOI: 10.1016/j.tcm.2019.10.001] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
126 Lee HS, Kim K, Jung S, Hong M, Kim BM, Yoo DS, Moon JW, Baek J, Hwang SW, Park SH, Yang SK, Han B, Song K, Ye BD. Effects of smoking on the association of human leukocyte antigen with ulcerative colitis. J Gastroenterol Hepatol 2019;34:1777-83. [PMID: 31038770 DOI: 10.1111/jgh.14695] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
127 Kobayashi Y, Ohfuji S, Kondo K, Fukushima W, Sasaki S, Kamata N, Yamagami H, Fujiwara Y, Suzuki Y, Hirota Y; Japanese Case-Control Study Group for Ulcerative Colitis. Association between dietary iron and zinc intake and development of ulcerative colitis: A case-control study in Japan. J Gastroenterol Hepatol 2019;34:1703-10. [PMID: 30821862 DOI: 10.1111/jgh.14642] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
128 Park S, Chun J, Han KD, Soh H, Kang EA, Lee HJ, Im JP, Kim JS. Dose-response relationship between cigarette smoking and risk of ulcerative colitis: a nationwide population-based study. J Gastroenterol 2019;54:881-90. [PMID: 31093771 DOI: 10.1007/s00535-019-01589-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
129 Thomas T, Chandan JS, Li VSW, Lai CY, Tang W, Bhala N, Kaplan GG, Ng SC, Ghosh S. Global smoking trends in inflammatory bowel disease: A systematic review of inception cohorts. PLoS One 2019;14:e0221961. [PMID: 31545811 DOI: 10.1371/journal.pone.0221961] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
130 Lin KD, Chiu GF, Waljee AK, Owyang SY, El-Zaatari M, Bishu S, Grasberger H, Zhang M, Wu DC, Kao JY. Effects of Anti-Helicobacter pylori Therapy on Incidence of Autoimmune Diseases, Including Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol 2019;17:1991-9. [PMID: 30580094 DOI: 10.1016/j.cgh.2018.12.014] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 8.0] [Reference Citation Analysis]
131 Piovani D, Danese S, Peyrin-Biroulet L, Nikolopoulos GK, Lytras T, Bonovas S. Environmental Risk Factors for Inflammatory Bowel Diseases: An Umbrella Review of Meta-analyses. Gastroenterology 2019;157:647-659.e4. [PMID: 31014995 DOI: 10.1053/j.gastro.2019.04.016] [Cited by in Crossref: 236] [Cited by in F6Publishing: 234] [Article Influence: 59.0] [Reference Citation Analysis]
132 Legeret C, Mählmann L, Gerber M, Kalak N, Köhler H, Holsboer-Trachsler E, Brand S, Furlano R. Favorable impact of long-term exercise on disease symptoms in pediatric patients with inflammatory bowel disease. BMC Pediatr 2019;19:297. [PMID: 31455308 DOI: 10.1186/s12887-019-1680-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
133 Du Y, Ding H, Vanarsa K, Soomro S, Baig S, Hicks J, Mohan C. Low dose Epigallocatechin Gallate Alleviates Experimental Colitis by Subduing Inflammatory Cells and Cytokines, and Improving Intestinal Permeability. Nutrients 2019;11:E1743. [PMID: 31362373 DOI: 10.3390/nu11081743] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
134 Agrawal M, Shah S, Patel A, Pinotti R, Colombel JF, Burisch J. Changing epidemiology of immune-mediated inflammatory diseases in immigrants: A systematic review of population-based studies. J Autoimmun 2019;105:102303. [PMID: 31351784 DOI: 10.1016/j.jaut.2019.07.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
135 Windsor JW, Kaplan GG. Evolving Epidemiology of IBD. Curr Gastroenterol Rep. 2019;21:40. [PMID: 31338613 DOI: 10.1007/s11894-019-0705-6] [Cited by in Crossref: 108] [Cited by in F6Publishing: 84] [Article Influence: 27.0] [Reference Citation Analysis]
136 Huang C, Shi G. Smoking and microbiome in oral, airway, gut and some systemic diseases. J Transl Med. 2019;17:225. [PMID: 31307469 DOI: 10.1186/s12967-019-1971-7] [Cited by in Crossref: 90] [Cited by in F6Publishing: 97] [Article Influence: 22.5] [Reference Citation Analysis]
137 Tian Y, Zhou Y, Huang S, Li J, Zhao K, Li X, Wen X, Li XA. Fecal microbiota transplantation for ulcerative colitis: a prospective clinical study. BMC Gastroenterol 2019;19:116. [PMID: 31272391 DOI: 10.1186/s12876-019-1010-4] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 7.5] [Reference Citation Analysis]
138 Zhao M, Burisch J. Impact of Genes and the Environment on the Pathogenesis and Disease Course of Inflammatory Bowel Disease. Dig Dis Sci 2019;64:1759-69. [PMID: 31073736 DOI: 10.1007/s10620-019-05648-w] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 8.3] [Reference Citation Analysis]
139 Oligschlaeger Y, Yadati T, Houben T, Condello Oliván CM, Shiri-Sverdlov R. Inflammatory Bowel Disease: A Stressed "Gut/Feeling". Cells 2019;8:E659. [PMID: 31262067 DOI: 10.3390/cells8070659] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 9.3] [Reference Citation Analysis]
140 Zhu L, Han J, Li L, Wang Y, Li Y, Zhang S. Claudin Family Participates in the Pathogenesis of Inflammatory Bowel Diseases and Colitis-Associated Colorectal Cancer. Front Immunol 2019;10:1441. [PMID: 31316506 DOI: 10.3389/fimmu.2019.01441] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 11.3] [Reference Citation Analysis]
141 Castro F, de Souza HSP. Dietary Composition and Effects in Inflammatory Bowel Disease. Nutrients 2019;11:E1398. [PMID: 31234325 DOI: 10.3390/nu11061398] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
142 Mokhtar NM, Nawawi KNM, Verasingam J, Zhiqin W, Sagap I, Azman ZAM, Mazlan L, Hamid HA, Yaacob NY, Rose IM, Den ELN, Wan MS, Raja Ali RA. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia. BMC Public Health 2019;19:550. [PMID: 31196184 DOI: 10.1186/s12889-019-6858-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
143 Liu L, Liang L, Liang H, Wang M, Lu B, Xue M, Deng J, Chen Y. Fusobacterium nucleatum Aggravates the Progression of Colitis by Regulating M1 Macrophage Polarization via AKT2 Pathway. Front Immunol 2019;10:1324. [PMID: 31249571 DOI: 10.3389/fimmu.2019.01324] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 9.5] [Reference Citation Analysis]
144 Friedman S, Nørgård BM. Confirming Complexity: Assessing Environmental and Genetic Risk Factors for Inflammatory Bowel Disease. Gastroenterology 2019;156:2124-5. [PMID: 31034830 DOI: 10.1053/j.gastro.2019.04.030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
145 Yang XY, Chen PF, He JH. High Consumption of Sweetened Beverages Might Increase the Risk of Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol 2019;17:1417-8. [PMID: 31126416 DOI: 10.1016/j.cgh.2018.11.053] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
146 Holik D, Včev A, Milostić-Srb A, Salinger Ž, Ivanišević Z, Včev I, Miškulin M. THE EFFECT OF DAILY PHYSICAL ACTIVITY ON THE ACTIVITY OF INFLAMMATORY BOWEL DISEASES IN THERAPY-FREE PATIENTS. Acta Clin Croat 2019;58:202-12. [PMID: 31819315 DOI: 10.20471/acc.2019.58.02.02] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
147 Yang Y, Xiang L, He J. Beverage intake and risk of Crohn disease: A meta-analysis of 16 epidemiological studies. Medicine (Baltimore) 2019;98:e15795. [PMID: 31124976 DOI: 10.1097/MD.0000000000015795] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
148 Sun J, Bao JY, Chen HY, Chen HN, Cui BX, Wang HH. Effect of different vitamin B12 derivatives on dextran sulfate sodium-induced colitis in mice. Shijie Huaren Xiaohua Zazhi 2019; 27(10): 611-617 [DOI: 10.11569/wcjd.v27.i10.611] [Reference Citation Analysis]
149 Kim YN, Jung Y. [Renal and Urinary Manifestations of Inflammatory Bowel Disease]. Korean J Gastroenterol 2019;73:260-8. [PMID: 31132832 DOI: 10.4166/kjg.2019.73.5.260] [Reference Citation Analysis]
150 Ramos GP, Papadakis KA. Mechanisms of Disease: Inflammatory Bowel Diseases. Mayo Clin Proc. 2019;94:155-165. [PMID: 30611442 DOI: 10.1016/j.mayocp.2018.09.013] [Cited by in Crossref: 275] [Cited by in F6Publishing: 289] [Article Influence: 68.8] [Reference Citation Analysis]
151 Olivera P, Danese S, Jay N, Natoli G, Peyrin-Biroulet L. Big data in IBD: a look into the future. Nat Rev Gastroenterol Hepatol 2019;16:312-21. [PMID: 30659247 DOI: 10.1038/s41575-019-0102-5] [Cited by in Crossref: 78] [Cited by in F6Publishing: 64] [Article Influence: 19.5] [Reference Citation Analysis]
152 Thomas T, Chandan JS, Harvey PR, Bhala N, Ghosh S, Nirantharakumar K, Trudgill NJ. The Risk of Inflammatory Bowel Disease in Subjects Presenting With Perianal Abscess: Findings From the THIN Database. J Crohns Colitis 2019;13:600-6. [PMID: 30544202 DOI: 10.1093/ecco-jcc/jjy210] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
153 Qazi T, Farraye FA. Sleep and Inflammatory Bowel Disease: An Important Bi-Directional Relationship. Inflamm Bowel Dis 2019;25:843-52. [PMID: 30388243 DOI: 10.1093/ibd/izy334] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
154 Chan SSM. Editorial: differences in sex-based incidence of inflammatory bowel diseases between Asia-Pacific and Western countries - are these due to differences in environment, access to healthcare, or pathophysiology? Aliment Pharmacol Ther 2019;49:1098-9. [PMID: 30920050 DOI: 10.1111/apt.15203] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
155 Shah SC, Khalili H, Chen CY, Ahn HS, Ng SC, Burisch J, Colombel JF. Sex-based differences in the incidence of inflammatory bowel diseases-pooled analysis of population-based studies from the Asia-Pacific region. Aliment Pharmacol Ther 2019;49:904-11. [PMID: 30773656 DOI: 10.1111/apt.15178] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 7.5] [Reference Citation Analysis]
156 Miller AW, Orr T, Dearing D, Monga M. Loss of function dysbiosis associated with antibiotics and high fat, high sugar diet. ISME J 2019;13:1379-90. [PMID: 30700790 DOI: 10.1038/s41396-019-0357-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
157 Ohfuji S. Epidemiology of Ulcerative Colitis in Japan. Epidemiological Studies of Specified Rare and Intractable Disease 2019. [DOI: 10.1007/978-981-13-1096-6_8] [Reference Citation Analysis]
158 Day AS. Exclusive Enteral Nutrition in Children With Crohn’s Disease. Dietary Interventions in Gastrointestinal Diseases 2019. [DOI: 10.1016/b978-0-12-814468-8.00009-0] [Reference Citation Analysis]
159 van der Sloot KWJ, Weersma RK, Dijkstra G, Alizadeh BZ. Development and validation of a web-based questionnaire to identify environmental risk factors for inflammatory bowel disease: the Groningen IBD Environmental Questionnaire (GIEQ). J Gastroenterol 2019;54:238-48. [PMID: 30109418 DOI: 10.1007/s00535-018-1501-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
160 Sood A, Ahuja V, Kedia S, Midha V, Mahajan R, Mehta V, Sudhakar R, Singh A, Kumar A, Puri AS, Tantry BV, Thapa BR, Goswami B, Behera BN, Ye BD, Bansal D, Desai D, Pai G, Yattoo GN, Makharia G, Wijewantha HS, Venkataraman J, Shenoy KT, Dwivedi M, Sahu MK, Bajaj M, Abdullah M, Singh N, Singh N, Abraham P, Khosla R, Tandon R, Misra SP, Nijhawan S, Sinha SK, Bopana S, Krishnaswamy S, Joshi S, Singh SP, Bhatia S, Gupta S, Bhatia S, Ghoshal UC. Diet and inflammatory bowel disease: The Asian Working Group guidelines. Indian J Gastroenterol 2019;38:220-46. [PMID: 31352652 DOI: 10.1007/s12664-019-00976-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
161 Chan JSH, Chao ACW, Cheung VCH, Wong SSK, Tang W, Wu JCY, Chan HLY, Chan FKL, Sung JJY, Ng SC. Gastrointestinal disease burden and mortality: A public hospital-based study from 2005 to 2014. J Gastroenterol Hepatol 2019;34:124-31. [PMID: 29995979 DOI: 10.1111/jgh.14377] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
162 Kumagai J, Taida T, Ogasawara S, Nakagawa T, Iino Y, Shingyoji A, Ishikawa K, Akizue N, Yamato M, Takahashi K, Ohta Y, Hamanaka S, Okimoto K, Nakamura M, Ohyama H, Saito K, Kusakabe Y, Maruoka D, Yasui S, Matsumura T, Sugiyama H, Sakai Y, Mikata R, Arai M, Katsuno T, Tsuyuguchi T, Kato N. Clinical characteristics and outcomes of primary sclerosing cholangitis and ulcerative colitis in Japanese patients. PLoS One. 2018;13:e0209352. [PMID: 30571774 DOI: 10.1371/journal.pone.0209352] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
163 Pei R, Martin DA, Valdez JC, Liu J, Kerby RL, Rey FE, Smyth JA, Liu Z, Bolling BW. Dietary Prevention of Colitis by Aronia Berry is Mediated Through Increased Th17 and Treg. Mol Nutr Food Res 2019;63:e1800985. [PMID: 30521111 DOI: 10.1002/mnfr.201800985] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
164 Sonoda A, Kamiyama N, Ozaka S, Gendo Y, Ozaki T, Hirose H, Noguchi K, Saechue B, Sachi N, Sakai K, Mizukami K, Hidano S, Murakami K, Kobayashi T. Oral administration of antibiotics results in fecal occult bleeding due to metabolic disorders and defective proliferation of the gut epithelial cell in mice. Genes Cells 2018;23:1043-55. [PMID: 30353943 DOI: 10.1111/gtc.12649] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
165 Xie R, Sun Y, Wu J, Huang S, Jin G, Guo Z, Zhang Y, Liu T, Liu X, Cao X, Wang B, Cao H. Maternal High Fat Diet Alters Gut Microbiota of Offspring and Exacerbates DSS-Induced Colitis in Adulthood. Front Immunol 2018;9:2608. [PMID: 30483266 DOI: 10.3389/fimmu.2018.02608] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 11.2] [Reference Citation Analysis]
166 Condelli S, Savio M. Interazione caffè-microbiota intestinale: una revisione della letteratura. PNEI REVIEW 2018. [DOI: 10.3280/pnei2018-002009] [Reference Citation Analysis]
167 Shah SC, Khalili H, Gower-Rousseau C, Olen O, Benchimol EI, Lynge E, Nielsen KR, Brassard P, Vutcovici M, Bitton A, Bernstein CN, Leddin D, Tamim H, Stefansson T, Loftus EV Jr, Moum B, Tang W, Ng SC, Gearry R, Sincic B, Bell S, Sands BE, Lakatos PL, Végh Z, Ott C, Kaplan GG, Burisch J, Colombel JF. Sex-Based Differences in Incidence of Inflammatory Bowel Diseases-Pooled Analysis of Population-Based Studies From Western Countries. Gastroenterology 2018;155:1079-1089.e3. [PMID: 29958857 DOI: 10.1053/j.gastro.2018.06.043] [Cited by in Crossref: 113] [Cited by in F6Publishing: 115] [Article Influence: 22.6] [Reference Citation Analysis]
168 Wang P, Hu J, Ghadermarzi S, Raza A, O'Connell D, Xiao A, Ayyaz F, Zhi M, Zhang Y, Parekh NK, Lazarev M, Parian A, Brant SR, Bedine M, Truta B, Hu P, Banerjee R, Hutfless SM. Smoking and Inflammatory Bowel Disease: A Comparison of China, India, and the USA. Dig Dis Sci 2018;63:2703-13. [PMID: 29862485 DOI: 10.1007/s10620-018-5142-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
169 Zhou G, Wu W, Yu L, Yu T, Yang W, Wang P, Zhang X, Cong Y, Liu Z. Tripartite motif-containing (TRIM) 21 negatively regulates intestinal mucosal inflammation through inhibiting TH1/TH17 cell differentiation in patients with inflammatory bowel diseases. Journal of Allergy and Clinical Immunology 2018;142:1218-1228.e12. [DOI: 10.1016/j.jaci.2017.09.038] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 6.8] [Reference Citation Analysis]
170 Segal Y. Autoimmune Hunger Games - a brief outline of the expanding role of nutrition in the aggravation and attenuation of autoimmune and rheumatic diseases. Autoimmun Rev 2018;17:1067-8. [PMID: 30213696 DOI: 10.1016/j.autrev.2018.05.006] [Reference Citation Analysis]
171 Song C, Yang J, Ye W, Zhang Y, Tang C, Li X, Zhou X, Xie Y. Urban–rural environmental exposure during childhood and subsequent risk of inflammatory bowel disease: a meta-analysis. Expert Review of Gastroenterology & Hepatology 2019;13:591-602. [DOI: 10.1080/17474124.2018.1511425] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
172 Bampton T, Tibrewal P, Kulkarni S. Clozapine and Azathioprine co-prescription: Is it safe? Asian J Psychiatr 2018;36:31-2. [PMID: 29890340 DOI: 10.1016/j.ajp.2018.05.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
173 Sanagapalli S, Ko Y, Kariyawasam V, Ng SC, Tang W, de Silva HJ, Chen M, Wu K, Aniwan S, Ng KK, Ong D, Ouyang Q, Hilmi I, Simadibrata M, Pisespongsa P, Gopikrishna S, Leong RW; IBD Sydney Organisation and the Asia-Pacific Crohn's and Colitis Epidemiology Study (ACCESS) Group. The association between new generation oral contraceptive pill and the development of inflammatory bowel diseases. Intest Res 2018;16:409-15. [PMID: 30090040 DOI: 10.5217/ir.2018.16.3.409] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
174 Wu X, Wang L, Tang L, Wang L, Cao S, Wu Q, Zhang Z, Li L. Salvianolic acid B alters the gut microbiota and mitigates colitis severity and associated inflammation. Journal of Functional Foods 2018;46:312-9. [DOI: 10.1016/j.jff.2018.04.068] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 6.6] [Reference Citation Analysis]
175 Zuo T, Kamm MA, Colombel JF, Ng SC. Urbanization and the gut microbiota in health and inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 2018;15:440-52. [PMID: 29670252 DOI: 10.1038/s41575-018-0003-z] [Cited by in Crossref: 133] [Cited by in F6Publishing: 126] [Article Influence: 26.6] [Reference Citation Analysis]
176 Cui G, Yuan A. A Systematic Review of Epidemiology and Risk Factors Associated With Chinese Inflammatory Bowel Disease. Front Med (Lausanne). 2018;5:183. [PMID: 29971235 DOI: 10.3389/fmed.2018.00183] [Cited by in Crossref: 59] [Cited by in F6Publishing: 62] [Article Influence: 11.8] [Reference Citation Analysis]
177 Kalubowila U, Liyanaarachchi T, Galketiya KB, Rathnayaka P, Piyasena INAP, Tennakoon S, Perera KMP, Pathirana SDMU, Wettewa DB, Ratnayake WRANMP, Raayiz RM, Dissanayaka DMIU. Epidemiology and clinical course of inflammatory bowel disease in the Central Province of Sri Lanka: A hospital-based study. JGH Open. 2018;2:129-133. [PMID: 30483577 DOI: 10.1002/jgh3.12058] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
178 Kedia S, Ahuja V. Is the emergence of inflammatory bowel disease a prime example of "the third epidemiological transition"? Indian J Gastroenterol 2018;37:183-5. [PMID: 29948992 DOI: 10.1007/s12664-018-0852-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
179 Amarapurkar AD, Amarapurkar DN, Rathi P, Sawant P, Patel N, Kamani P, Rawal K, Baijal R, Sonawane A, Narawane N, Kolekar S, Totla N. Risk factors for inflammatory bowel disease: A prospective multi-center study. Indian J Gastroenterol 2018;37:189-95. [PMID: 29987750 DOI: 10.1007/s12664-018-0850-0] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 7.0] [Reference Citation Analysis]
180 Kobayashi T, Hisamatsu T, Suzuki Y, Ogata H, Andoh A, Araki T, Hokari R, Iijima H, Ikeuchi H, Ishiguro Y, Kato S, Kunisaki R, Matsumoto T, Motoya S, Nagahori M, Nakamura S, Nakase H, Tsujikawa T, Sasaki M, Yokoyama K, Yoshimura N, Watanabe K, Katafuchi M, Watanabe M, Hibi T. Predicting outcomes to optimize disease management in inflammatory bowel disease in Japan: their differences and similarities to Western countries. Intest Res 2018;16:168-77. [PMID: 29743830 DOI: 10.5217/ir.2018.16.2.168] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
181 Ó Cuív P, Giri R, Hoedt EC, McGuckin MA, Begun J, Morrison M. Enterococcus faecalis AHG0090 is a Genetically Tractable Bacterium and Produces a Secreted Peptidic Bioactive that Suppresses Nuclear Factor Kappa B Activation in Human Gut Epithelial Cells. Front Immunol 2018;9:790. [PMID: 29720977 DOI: 10.3389/fimmu.2018.00790] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
182 Girard-madoux MJ, Gomez de Agüero M, Ganal-vonarburg SC, Mooser C, Belz GT, Macpherson AJ, Vivier E. The immunological functions of the Appendix: An example of redundancy? Seminars in Immunology 2018;36:31-44. [DOI: 10.1016/j.smim.2018.02.005] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 8.6] [Reference Citation Analysis]
183 Cuív PÓ, Giria R, Hoedt EC, Mcguckin MA, Begun J, Morrison M. Enterococcus faecalisAHG0090 is a genetically tractable bacterium and produces a secreted peptidic bioactive that suppresses NF-kB activation in human gut epithelial cells.. [DOI: 10.1101/275719] [Reference Citation Analysis]
184 Palmela C, Chevarin C, Xu Z, Torres J, Sevrin G, Hirten R, Barnich N, Ng SC, Colombel JF. Adherent-invasive Escherichia coli in inflammatory bowel disease. Gut 2018;67:574-87. [PMID: 29141957 DOI: 10.1136/gutjnl-2017-314903] [Cited by in Crossref: 237] [Cited by in F6Publishing: 217] [Article Influence: 47.4] [Reference Citation Analysis]
185 Sarabi Asiabar A, Asadzadeh Aghdaei H, Sabokbar A, Zali MR, Feizabadi MM. Investigation of adherent-invasive E. coli in patients with Crohn's disease. Med J Islam Repub Iran 2018;32:11. [PMID: 30159262 DOI: 10.14196/mjiri.32.11] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
186 Shi HY, Levy AN, Trivedi HD, Chan FKL, Ng SC, Ananthakrishnan AN. Ethnicity Influences Phenotype and Outcomes in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis of Population-based Studies. Clin Gastroenterol Hepatol 2018;16:190-197.e11. [PMID: 28603049 DOI: 10.1016/j.cgh.2017.05.047] [Cited by in Crossref: 62] [Cited by in F6Publishing: 41] [Article Influence: 12.4] [Reference Citation Analysis]
187 Zhou Y, Xu ZZ, He Y, Yang Y, Liu L, Lin Q, Nie Y, Li M, Zhi F, Liu S, Amir A, González A, Tripathi A, Chen M, Wu GD, Knight R, Zhou H, Chen Y. Gut Microbiota Offers Universal Biomarkers across Ethnicity in Inflammatory Bowel Disease Diagnosis and Infliximab Response Prediction. mSystems 2018;3:e00188-17. [PMID: 29404425 DOI: 10.1128/mSystems.00188-17] [Cited by in Crossref: 127] [Cited by in F6Publishing: 137] [Article Influence: 25.4] [Reference Citation Analysis]
188 Aniwan S, Tremaine WJ, Raffals LE, Kane SV, Loftus EV Jr. Antibiotic Use and New-Onset Inflammatory Bowel Disease in Olmsted County, Minnesota: A Population-Based Case-Control Study. J Crohns Colitis 2018;12:137-44. [PMID: 29029150 DOI: 10.1093/ecco-jcc/jjx135] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
189 Nie JY, Zhao Q. Beverage consumption and risk of ulcerative colitis: Systematic review and meta-analysis of epidemiological studies. Medicine (Baltimore) 2017;96:e9070. [PMID: 29245319 DOI: 10.1097/MD.0000000000009070] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 6.6] [Reference Citation Analysis]
190 Ananthakrishnan AN, Bernstein CN, Iliopoulos D, Macpherson A, Neurath MF, Ali RAR, Vavricka SR, Fiocchi C. Environmental triggers in IBD: a review of progress and evidence. Nat Rev Gastroenterol Hepatol 2018;15:39-49. [PMID: 29018271 DOI: 10.1038/nrgastro.2017.136] [Cited by in Crossref: 374] [Cited by in F6Publishing: 328] [Article Influence: 74.8] [Reference Citation Analysis]
191 Theochari NA, Stefanopoulos A, Mylonas KS, Economopoulos KP. Antibiotics exposure and risk of inflammatory bowel disease: a systematic review. Scand J Gastroenterol 2018;53:1-7. [PMID: 29022402 DOI: 10.1080/00365521.2017.1386711] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 8.6] [Reference Citation Analysis]
192 Arora U, Ananthakrishnan AN, Kedia S, Bopanna S, Mouli PV, Yadav DP, Makharia GK, Yajnik V, Ahuja V. Effect of oral tobacco use and smoking on outcomes of Crohn's disease in India. J Gastroenterol Hepatol 2018;33:134-40. [PMID: 28475826 DOI: 10.1111/jgh.13815] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
193 Zhang Z, Wu X, Cao S, Wang L, Wang D, Yang H, Feng Y, Wang S, Li L. Caffeic acid ameliorates colitis in association with increased Akkermansia population in the gut microbiota of mice. Oncotarget 2016;7:31790-9. [PMID: 27177331 DOI: 10.18632/oncotarget.9306] [Cited by in Crossref: 83] [Cited by in F6Publishing: 86] [Article Influence: 13.8] [Reference Citation Analysis]
194 Engels M, Cross RK, Long MD. Exercise in patients with inflammatory bowel diseases: current perspectives. Clin Exp Gastroenterol. 2018;11:1-11. [PMID: 29317842 DOI: 10.2147/ceg.s120816] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 5.8] [Reference Citation Analysis]
195 Zhai H, Huang W, Liu A, Li Q, Hao Q, Ma L, Yang F, Zhang S. Current smoking improves ulcerative colitis patients' disease behaviour in the northwest of China. Prz Gastroenterol 2017;12:286-90. [PMID: 29358998 DOI: 10.5114/pg.2017.72104] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
196 Qiu X, Ma J, Jiao C, Mao X, Zhao X, Lu M, Wang K, Zhang H. Alterations in the mucosa-associated fungal microbiota in patients with ulcerative colitis. Oncotarget 2017;8:107577-88. [PMID: 29296188 DOI: 10.18632/oncotarget.22534] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 6.5] [Reference Citation Analysis]
197 Bernstein CN. Large Registry Epidemiology in IBD. Inflamm Bowel Dis 2017;23:1941-9. [PMID: 28991858 DOI: 10.1097/MIB.0000000000001279] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
198 Bernstein CN. Review article: changes in the epidemiology of inflammatory bowel disease-clues for aetiology. Aliment Pharmacol Ther 2017;46:911-9. [PMID: 28949021 DOI: 10.1111/apt.14338] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 9.0] [Reference Citation Analysis]
199 Xu L, Lochhead P, Ko Y, Claggett B, Leong RW, Ananthakrishnan AN. Systematic review with meta-analysis: breastfeeding and the risk of Crohn's disease and ulcerative colitis. Aliment Pharmacol Ther 2017;46:780-9. [PMID: 28892171 DOI: 10.1111/apt.14291] [Cited by in Crossref: 97] [Cited by in F6Publishing: 84] [Article Influence: 16.2] [Reference Citation Analysis]
200 Park SC, Jeen YT. Role of Smoking as a Risk Factor in East Asian Patients with Crohn's Disease. Gut Liver. 2017;11:7-8. [PMID: 28053297 DOI: 10.5009/gnl16534] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
201 Hibi T, Imai Y, Murata Y, Matsushima N, Zheng R, Gasink C. Efficacy and safety of ustekinumab in Japanese patients with moderately to severely active Crohn's disease: a subpopulation analysis of phase 3 induction and maintenance studies. Intest Res 2017;15:475-86. [PMID: 29142515 DOI: 10.5217/ir.2017.15.4.475] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
202 Mählmann L, Gerber M, Furlano RI, Legeret C, Kalak N, Holsboer-trachsler E, Brand S. Aerobic exercise training in children and adolescents with inflammatory bowel disease: Influence on psychological functioning, sleep and physical performance – An exploratory trial. Mental Health and Physical Activity 2017;13:30-9. [DOI: 10.1016/j.mhpa.2017.09.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
203 Sorrentino D. The Coming of Age of Inflammatory Bowel Diseases in Asia. Inflamm Intest Dis. 2017;2:93-94. [PMID: 30018959 DOI: 10.1159/000480731] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
204 van der Sloot KWJ, Amini M, Peters V, Dijkstra G, Alizadeh BZ. Inflammatory Bowel Diseases: Review of Known Environmental Protective and Risk Factors Involved. Inflamm Bowel Dis 2017;23:1499-509. [PMID: 28777099 DOI: 10.1097/MIB.0000000000001217] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 9.0] [Reference Citation Analysis]
205 Niewiadomski O, Studd C, Wilson J, Williams J, Hair C, Knight R, Prewett E, Dabkowski P, Alexander S, Allen B, Dowling D, Connell W, Desmond P, Bell S. Influence of food and lifestyle on the risk of developing inflammatory bowel disease. Intern Med J 2016;46:669-76. [PMID: 27059169 DOI: 10.1111/imj.13094] [Cited by in Crossref: 49] [Cited by in F6Publishing: 55] [Article Influence: 8.2] [Reference Citation Analysis]
206 Gajendran M, Loganathan P, Catinella AP, Hashash JG. A comprehensive review and update on Crohn's disease. Dis Mon. 2018;64:20-57. [PMID: 28826742 DOI: 10.1016/j.disamonth.2017.07.001] [Cited by in Crossref: 190] [Cited by in F6Publishing: 209] [Article Influence: 31.7] [Reference Citation Analysis]
207 Hwang SW, Seo H, Kim GU, Song EM, Seo M, Park SH, Kwon E, Lee HS, Yang DH, Kim KJ, Ye BD, Byeon JS, Myung SJ, Kim JH, Yang SK. Underestimation of Smoking Rates in an East Asian Population with Crohn's Disease. Gut Liver 2017;11:73-8. [PMID: 27728967 DOI: 10.5009/gnl16194] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
208 Zhou M, He J, Shen Y, Zhang C, Wang J, Chen Y. New Frontiers in Genetics, Gut Microbiota, and Immunity: A Rosetta Stone for the Pathogenesis of Inflammatory Bowel Disease. Biomed Res Int 2017;2017:8201672. [PMID: 28831399 DOI: 10.1155/2017/8201672] [Cited by in Crossref: 43] [Cited by in F6Publishing: 49] [Article Influence: 7.2] [Reference Citation Analysis]
209 de Souza HSP. Etiopathogenesis of inflammatory bowel disease: today and tomorrow. Curr Opin Gastroenterol 2017;33:222-9. [PMID: 28402995 DOI: 10.1097/MOG.0000000000000364] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 6.5] [Reference Citation Analysis]
210 Zhang Z, Wu X, Cao S, Cromie M, Shen Y, Feng Y, Yang H, Li L. Chlorogenic Acid Ameliorates Experimental Colitis by Promoting Growth of Akkermansia in Mice. Nutrients 2017;9:E677. [PMID: 28661454 DOI: 10.3390/nu9070677] [Cited by in Crossref: 74] [Cited by in F6Publishing: 82] [Article Influence: 12.3] [Reference Citation Analysis]
211 Dahan S, Segal Y, Shoenfeld Y. Dietary factors in rheumatic autoimmune diseases: a recipe for therapy? Nat Rev Rheumatol 2017;13:348-58. [PMID: 28405001 DOI: 10.1038/nrrheum.2017.42] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 7.2] [Reference Citation Analysis]
212 Kedia S, Ahuja V. Epidemiology of Inflammatory Bowel Disease in India: The Great Shift East. Inflamm Intest Dis. 2017;2:102-115. [PMID: 30018961 DOI: 10.1159/000465522] [Cited by in Crossref: 69] [Cited by in F6Publishing: 77] [Article Influence: 11.5] [Reference Citation Analysis]
213 Naidu J, Wong Zh, Palaniappan Sh, Ngiu ChS, Yaacob NY, Abdul Hamid H, Hikmah Elias M, Mokhtar NM, Raja Ali RA. Radiation Exposure in Patients with Inflammatory Bowel Disease: a Fourteen-Year Review at a Tertiary Care Centre in Malaysia. Asian Pac J Cancer Prev 2017;18:933-9. [PMID: 28545190 DOI: 10.22034/APJCP.2017.18.4.933] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
214 Dong X, Liu Z, Lan D, Niu J, Miao J, Yang G, Zhang F, Sun Y, Wang K, Miao Y. Critical role of Keratin 1 in maintaining epithelial barrier and correlation of its down-regulation with the progression of inflammatory bowel disease. Gene 2017;608:13-9. [DOI: 10.1016/j.gene.2017.01.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
215 He Y, Mao R, Chen F, Xu PP, Chen BL, Wu Y, Qiu Y, Zhang SH, Feng R, Zeng ZR, Ben-Horin S, Chen MH. Thalidomide induces clinical remission and mucosal healing in adults with active Crohn's disease: a prospective open-label study. Therap Adv Gastroenterol 2017;10:397-406. [PMID: 28507598 DOI: 10.1177/1756283X17698910] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
216 Jin S, Zhao D, Cai C, Song D, Shen J, Xu A, Qiao Y, Ran Z, Zheng Q. Low-dose penicillin exposure in early life decreases Th17 and the susceptibility to DSS colitis in mice through gut microbiota modification. Sci Rep 2017;7:43662. [PMID: 28272549 DOI: 10.1038/srep43662] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 7.0] [Reference Citation Analysis]
217 Kaplan GG, Ng SC. Understanding and Preventing the Global Increase of Inflammatory Bowel Disease. Gastroenterology 2017;152:313-321.e2. [PMID: 27793607 DOI: 10.1053/j.gastro.2016.10.020] [Cited by in Crossref: 528] [Cited by in F6Publishing: 542] [Article Influence: 88.0] [Reference Citation Analysis]
218 Zamani S, Zali MR, Aghdaei HA, Sechi LA, Niegowska M, Caggiu E, Keshavarz R, Mosavari N, Feizabadi MM. Mycobacterium avium subsp. paratuberculosis and associated risk factors for inflammatory bowel disease in Iranian patients. Gut Pathog 2017;9:1. [PMID: 28053669 DOI: 10.1186/s13099-016-0151-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
219 Van Der Sloot KW, Joshi AD, Bellavance DR, Gilpin KK, Stewart KO, Lochhead P, Garber JJ, Giallourakis C, Yajnik V, Ananthakrishnan AN, Alizadeh BZ, Xavier RJ, Khalili H. Visceral Adiposity, Genetic Susceptibility, and Risk of Complications Among Individuals with Crohn's Disease. Inflamm Bowel Dis 2017;23:82-8. [PMID: 27893544 DOI: 10.1097/MIB.0000000000000978] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 7.0] [Reference Citation Analysis]
220 Ananthakrishnan AN. The New Face of IBD. Clinical Gastroenterology 2017. [DOI: 10.1007/978-3-319-53763-4_1] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
221 Moura FA, Goulart MOF. Inflammatory Bowel Diseases. Gastrointestinal Tissue. Elsevier; 2017. pp. 99-112. [DOI: 10.1016/b978-0-12-805377-5.00007-2] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
222 Forbes A, Escher J, Hébuterne X, Kłęk S, Krznaric Z, Schneider S, Shamir R, Stardelova K, Wierdsma N, Wiskin AE, Bischoff SC. ESPEN guideline: Clinical nutrition in inflammatory bowel disease. Clin Nutr 2017;36:321-47. [PMID: 28131521 DOI: 10.1016/j.clnu.2016.12.027] [Cited by in Crossref: 342] [Cited by in F6Publishing: 353] [Article Influence: 48.9] [Reference Citation Analysis]
223 Kuenzig ME, Lee SM, Eksteen B, Seow CH, Barnabe C, Panaccione R, Kaplan GG. Smoking influences the need for surgery in patients with the inflammatory bowel diseases: a systematic review and meta-analysis incorporating disease duration. BMC Gastroenterol. 2016;16:143. [PMID: 28003021 DOI: 10.1186/s12876-016-0555-8] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
224 Konkel L. Inflammatory Bowel Disease in Asia: A Second Chance at Uncovering Environmental Factors. Environ Health Perspect 2016;124:A49-54. [PMID: 26930697 DOI: 10.1289/ehp.124-A49] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
225 He C, Shi Y, Wu R, Sun M, Fang L, Wu W, Liu C, Tang M, Li Z, Wang P, Cong Y, Liu Z. miR-301a promotes intestinal mucosal inflammation through induction of IL-17A and TNF-α in IBD. Gut 2016;65:1938-50. [PMID: 26338824 DOI: 10.1136/gutjnl-2015-309389] [Cited by in Crossref: 104] [Cited by in F6Publishing: 98] [Article Influence: 14.9] [Reference Citation Analysis]
226 Torres J, Mehandru S, Colombel JF, Peyrin-Biroulet L. Crohn's disease. Lancet. 2017;389:1741-1755. [PMID: 27914655 DOI: 10.1016/s0140-6736(16)31711-1] [Cited by in Crossref: 955] [Cited by in F6Publishing: 999] [Article Influence: 136.4] [Reference Citation Analysis]
227 Wang Q, Xu KQ, Qin XR, Wen-Lu, Yan-Liu, Wang XY. Association between physical activity and inflammatory bowel disease risk: A meta-analysis. Dig Liver Dis 2016;48:1425-31. [PMID: 27671622 DOI: 10.1016/j.dld.2016.08.129] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
228 Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF. Ulcerative colitis. Lancet. 2017;389:1756-1770. [PMID: 27914657 DOI: 10.1016/s0140-6736(16)32126-2] [Cited by in Crossref: 1306] [Cited by in F6Publishing: 1116] [Article Influence: 186.6] [Reference Citation Analysis]
229 Kaplan GG, Ng SC. Globalisation of inflammatory bowel disease: perspectives from the evolution of inflammatory bowel disease in the UK and China. Lancet Gastroenterol Hepatol. 2016;1:307-316. [PMID: 28404201 DOI: 10.1016/s2468-1253(16)30077-2] [Cited by in Crossref: 99] [Cited by in F6Publishing: 86] [Article Influence: 14.1] [Reference Citation Analysis]
230 Molina-Infante J, Schoepfer AM, Lucendo AJ, Dellon ES. Eosinophilic esophagitis: What can we learn from Crohn's disease? United European Gastroenterol J 2017;5:762-72. [PMID: 29026590 DOI: 10.1177/2050640616672953] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
231 Ray G. Inflammatory bowel disease in India - Past, present and future. World J Gastroenterol 2016; 22(36): 8123-8136 [PMID: 27688654 DOI: 10.3748/wjg.v22.i36.8123] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 34] [Article Influence: 4.7] [Reference Citation Analysis]
232 Zhou G, Yu L, Yang W, Wu W, Fang L, Liu Z. Blockade of PLD2 Ameliorates Intestinal Mucosal Inflammation of Inflammatory Bowel Disease. Mediators Inflamm 2016;2016:2543070. [PMID: 27721573 DOI: 10.1155/2016/2543070] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
233 Cholapranee A, Ananthakrishnan AN. Environmental Hygiene and Risk of Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis. Inflamm Bowel Dis 2016;22:2191-9. [PMID: 27482977 DOI: 10.1097/MIB.0000000000000852] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 6.0] [Reference Citation Analysis]
234 Li G, Ren J, Wang G, Hu Q, Wu Q, Wu X, Li R, Guo K, Li Y, Gu G, Ren H, Hong Z, Li J. Disease-related knowledge and smoking behavior of patients with Crohn's disease. Dig Liver Dis 2016;48:1006-11. [PMID: 27289332 DOI: 10.1016/j.dld.2016.05.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
235 Dolan KT, Chang EB. Diet, gut microbes, and the pathogenesis of inflammatory bowel diseases. Mol Nutr Food Res 2017;61. [PMID: 27346644 DOI: 10.1002/mnfr.201600129] [Cited by in Crossref: 64] [Cited by in F6Publishing: 74] [Article Influence: 9.1] [Reference Citation Analysis]
236 Lui RNS, Ng SC. The Same Intestinal Inflammatory Disease despite Different Genetic Risk Factors in the East and West? Inflamm Intest Dis 2016;1:78-84. [PMID: 29922661 DOI: 10.1159/000446625] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
237 Nakase H, Keum B, Ye BD, Park SJ, Koo HS, Eun CS. Treatment of inflammatory bowel disease in Asia: The results of a multinational web-based survey in the 2(nd) Asian Organization of Crohn's and Colitis (AOCC) meeting in Seoul. Intest Res. 2016;14:231-239. [PMID: 27433145 DOI: 10.5217/ir.2016.14.3.231] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
238 Zhang Q, Zhang C, Li X, Yu Y, Liang K, Shan X, Zhao K, Niu Q, Tian Z. WISP1 Is Increased in Intestinal Mucosa and Contributes to Inflammatory Cascades in Inflammatory Bowel Disease. Dis Markers 2016;2016:3547096. [PMID: 27403031 DOI: 10.1155/2016/3547096] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
239 Sun W, Han X, Wu S, Yang C. Tonsillectomy and the risk of inflammatory bowel disease: A systematic review and meta-analysis. J Gastroenterol Hepatol 2016;31:1085-94. [PMID: 26678358 DOI: 10.1111/jgh.13273] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
240 Ng WK, Wong SH, Ng SC. Changing epidemiological trends of inflammatory bowel disease in Asia. Intest Res. 2016;14:111-119. [PMID: 27175111 DOI: 10.5217/ir.2016.14.2.111] [Cited by in Crossref: 202] [Cited by in F6Publishing: 212] [Article Influence: 28.9] [Reference Citation Analysis]
241 Liu TC, Stappenbeck TS. Genetics and Pathogenesis of Inflammatory Bowel Disease. Annu Rev Pathol. 2016;11:127-148. [PMID: 26907531 DOI: 10.1146/annurev-pathol-012615-044152] [Cited by in Crossref: 149] [Cited by in F6Publishing: 153] [Article Influence: 21.3] [Reference Citation Analysis]
242 Dutta AK, Chacko A. Influence of environmental factors on the onset and course of inflammatory bowel disease. World J Gastroenterol 2016; 22(3): 1088-1100 [PMID: 26811649 DOI: 10.3748/wjg.v22.i3.1088] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
243 Lindström U, Forsblad-d'Elia H, Askling J, Kristensen LE, Lie E, Exarchou S, Jacobsson L. Perinatal characteristics, older siblings, and risk of ankylosing spondylitis: a case-control study based on national registers. Arthritis Res Ther 2016;18:16. [PMID: 26785608 DOI: 10.1186/s13075-016-0917-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
244 Kaplan GG, Jess T. The Changing Landscape of Inflammatory Bowel Disease: East Meets West. Gastroenterology 2016;150:24-6. [PMID: 26592321 DOI: 10.1053/j.gastro.2015.11.029] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
245 Ooi CJ, Makharia GK, Hilmi I, Gibson PR, Fock KM, Ahuja V, Ling KL, Lim WC, Thia KT, Wei SC, Leung WK, Koh PK, Gearry RB, Goh KL, Ouyang Q, Sollano J, Manatsathit S, de Silva HJ, Rerknimitr R, Pisespongsa P, Abu Hassan MR, Sung J, Hibi T, Boey CC, Moran N, Leong RW; Asia Pacific Association of Gastroenterology (APAGE) Working Group on Inflammatory Bowel Disease. Asia Pacific Consensus Statements on Crohn's disease. Part 1: Definition, diagnosis, and epidemiology: (Asia Pacific Crohn's Disease Consensus--Part 1). J Gastroenterol Hepatol 2016;31:45-55. [PMID: 25819140 DOI: 10.1111/jgh.12956] [Cited by in Crossref: 80] [Cited by in F6Publishing: 79] [Article Influence: 11.4] [Reference Citation Analysis]
246 Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol 2015;12:720-7. [PMID: 26323879 DOI: 10.1038/nrgastro.2015.150] [Cited by in Crossref: 1157] [Cited by in F6Publishing: 1042] [Article Influence: 144.6] [Reference Citation Analysis]
247 Ananthakrishnan AN, Khalili H, Song M, Higuchi LM, Richter JM, Nimptsch K, Wu K, Chan AT. High School Diet and Risk of Crohn's Disease and Ulcerative Colitis. Inflamm Bowel Dis 2015;21:2311-9. [PMID: 26236952 DOI: 10.1097/MIB.0000000000000501] [Cited by in Crossref: 15] [Cited by in F6Publishing: 40] [Article Influence: 1.9] [Reference Citation Analysis]
248 Tseng CC, Yen JH, Tsai WC, Ou TT, Wu CC, Sung WY, Hsieh MC, Chang SJ. Reduced incidence of Crohn's disease in systemic sclerosis: a nationwide population study. BMC Musculoskelet Disord 2015;16:251. [PMID: 26370572 DOI: 10.1186/s12891-015-0693-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
249 Lakatos PL, Burisch J. Environment and invironment in IBDs: partners in crime. Gut 2015;64:1009-10. [PMID: 25336112 DOI: 10.1136/gutjnl-2014-308460] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
250 Hu PJ. Inflammatory Bowel Disease in Asia: The Challenges and Opportunities. Intest Res. 2015;13:188-190. [PMID: 26130991 DOI: 10.5217/ir.2015.13.3.188] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
251 Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol 2015;12:205-17. [PMID: 25732745 DOI: 10.1038/nrgastro.2015.34] [Cited by in Crossref: 880] [Cited by in F6Publishing: 789] [Article Influence: 110.0] [Reference Citation Analysis]
252 Zatorski H, Sałaga M, Zielińska M, Piechota-Polańczyk A, Owczarek K, Kordek R, Lewandowska U, Chen C, Fichna J. Experimental colitis in mice is attenuated by topical administration of chlorogenic acid. Naunyn Schmiedebergs Arch Pharmacol 2015;388:643-51. [PMID: 25743575 DOI: 10.1007/s00210-015-1110-9] [Cited by in Crossref: 48] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
253 Guo AY, Stevens BW, Wilson RG, Russell CN, Cohen MA, Sturgeon HC, Thornton A, Giallourakis C, Khalili H, Nguyen DD. Early life environment and natural history of inflammatory bowel diseases. BMC Gastroenterol. 2014;14:216. [PMID: 25510175 DOI: 10.1186/s12876-014-0216-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
254 Kaplan GG. IBD: Global variations in environmental risk factors for IBD. Nat Rev Gastroenterol Hepatol 2014;11:708-9. [PMID: 25348851 DOI: 10.1038/nrgastro.2014.182] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]